IDH1 and central nervous system cancer: The findings on miRNA-16-1 expression are rather inconclusive:its level is reduced in gliomas with the mutated IDH1phenotype compared to wild-type IDH1 tissues;meanwhile, reduced expression of this miRNA contributes to tumor proliferation[34, 35].